TIDMIHC
Inspiration Healthcare Group PLC
02 November 2023
Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Company" or the "Group")
Launch of SLE1500 Non-Invasive Ventilator
Strengthens portfolio and expands access to neonatal respiratory
market
Inspiration Healthcare Group plc (AIM: IHC), the global medical
technology company pioneering best-in-class, specialist neonatal
intensive care medical devices, announces the launch of the
SLE1500, the latest addition to its specialist neonatal ventilator
range. The SLE1500 is a compact respiratory support system that
provides non-invasive ventilation ("NIV") modes to meet the needs
of the smallest and most vulnerable neonatal patients requiring
respiratory support, helping to protect their fragile lungs.
NIV is considered the gold standard of care for preterm infants
with respiratory distress syndrome (RDS)(1) and is gradually
becoming the first choice for respiratory support(2) . The SLE1500
has been specifically designed to meet the special needs of some of
the most vulnerable babies, starting in the delivery room, to
augment their first breaths of life and as they move through their
stay in neonatal intensive care. The SLE1500 system offers six
non-invasive delivery options in one machine; nasal Continuous
Positive Airway Pressure (nCPAP) both flow and pressure controlled,
high flow oxygen therapy, and manual flow for use with therapies
like bubble CPAP, all of which can be augmented with Pulse Oximetry
(SpO(2) ) and / or automatic oxygen control (auto FiO(2) ) through
OxyGenie(R). Oxygenie(R), the Company's patented algorithmic oxygen
controller, provides second by second control of oxygenation,
allowing the baby to spend more time in its target oxygen
saturation and staff to spend more time caring for the infant, thus
improving outcomes.(3)
Neil Campbell, CEO of Inspiration Healthcare, commented: " We
are delighted to extend our differentiated best-in-class ventilator
product range with the launch of our new SLE1500 respiratory
support system, which will enable us to support more babies. The
need for non-invasive ventilation is paramount for the effective
treatment and care of the smallest and most vulnerable neonates.
The SLE1500 strengthens our ventilator product range and
complements our range of respiratory consumables allowing us to
offer better solutions to our customers worldwide.
"Our initial launch is focused on the UK and Australia, with
other market introductions due to follow, subject to regulatory
approvals. We are excited about the potential for the SLE1500,
which demonstrates a key part of our growth strategy and our
continued R&D commitment to pioneer innovative technologies to
help save lives daily."
1.Non-invasive ventilatory support in neonates: An
evidence-based update Paediatric Respiratory Reviews Volume 44 ,
December 2022, Pages 11-18 Ramadan A. Mahmoud , Gerd Schmalisch ,
Abhishek Oswal, Charles Christoph Roehr
2.Non-invasive Respiratory Support in Neonates: A Review of
Current Evidence and Practices Indian J Pediatr. 2021; 88(7):
670--678. Rajendra Prasad Anne 1 and Srinivas Murki
3.The effect of automated oxygen control on clinical outcomes in
preterm infants: a pre- and post-implementation cohort study
European Journal of Pediatrics (2021) 180:2107--2113 H. H.
Salverda, N. J. Oldenburger1 & M. Rijken, S. C. Pauws P. A.
Dargaville, A. B. te Pas1
For further information, please contact:
Inspiration Healthcare Group Tel: +44 (0)330 175 0000
plc
Neil Campbell, Chief Executive
Officer
Alan Olby, Chief Financial Officer
Walbrook PR Ltd (Media and Investor Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com
Relations)
Anna Dunphy Mob: +44 (0) 7876 741 001
Stephanie Cuthbert Mob: +44 (0) 7796 794 663
Louis Ashe-Jepson Mob: +44 (0) 7747 515 393
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) is a global provider of
medical technology for use in neonatal intensive care &
operating theatres. The Company provides high quality innovative
products to patients around the world which help to improve patient
outcomes and it actively invests in innovative product
opportunities and disruptive technologies.
The Company has key own brand products that can be used within
the first days of life to help premature and sick babies; helping
resuscitation and stabilisation in the first moments of life
through to preventing brain damage and both invasive and
non-invasive respiratory support in terms of capital equipment and
disposable medical devices. Additionally, the Company has its own
range of products for maintaining normothermia pre, during and
post-surgery.
Since September 2019, the Company has acquired Vio Holdings a
designer, manufacturer and supplier of single use respiratory
products and sterile medical consumables and S.L.E., a leading
designer, manufacturer and global provider of neonatal ventilation
products. The Group generates approximately 58% of its revenues
from export markets and more than half of its revenues come from
its own-branded products.
With product availability actively promoted to over 80 countries
through a distribution network, Inspiration Healthcare's success
has been built on continuous innovation, excellent customer service
and an inherent commitment to improving patient outcomes, working
in close collaboration with key opinion leaders across the
globe.
In the UK and Ireland, the Group has direct sales teams selling
Group Branded and complementary products from third parties, with
an additional range of home healthcare products. This is supported
by Technical Support for planned preventative maintenance and
emergency assistance.
The Group operates from various sites in the UK for R&D,
Marketing and operations with manufacturing based in Croydon (south
London) and Hailsham (East Sussex). The Group's Head Office is
located in Crawley, a short distance from London's Gatwick
Airport.
Further information on Inspiration Healthcare can be found at
www.inspirationhealthcaregroup.com
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAEASFFEEDDFFA
(END) Dow Jones Newswires
November 02, 2023 03:00 ET (07:00 GMT)
Inspiration Healthcare (LSE:IHC)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Inspiration Healthcare (LSE:IHC)
Gráfica de Acción Histórica
De May 2023 a May 2024